TAVI – not worth the money?

rpaicu —  October 4, 2012 — Leave a comment

TAVI is more expensive than a traditional AVR, doubles your risk of stroke and major vascular events, and outcome benefits are far from established. There is also a financial scandal reminiscent of the Manny Rivers affair, argues this analysis in the BMJ. Cheers to Mark L for sending this in.

TAVI – risky and costly Van Brabandt BMJ 12

No Comments

Be the first to start the conversation!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s